Patents
Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)
05/2009
05/07/2009US20090118164 Methods and compounds for the targeted delivery of agents to bone for interaction therewith
05/06/2009EP2055189A1 Glycopegylation methods and proteins/peptides produced by the methods
05/06/2009EP1309336B1 Derivatives of laspartomycin and preparation and use thereof
05/06/2009CN101423547A Purification method of teicoplanin
05/05/2009US7527798 Composition and method for preventing or treating a virus infection
04/2009
04/29/2009EP1487863B1 Process for purifying glycopeptide phospohonate derivatives
04/28/2009US7524821 Scaffolded maleimide clusters for multivalent peptide assembly
04/28/2009US7524502 Modified anti-TNF alpha antibody
04/22/2009EP2049144A2 Glycosylation of peptides via o-linked glycosylation sequences
04/16/2009WO2009046618A1 Deshydroxy vancomycin, the preparation, pharmaceutical composition and the use
04/14/2009US7517855 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
04/09/2009WO2009016384A3 Gsk-3 inhibitors
04/09/2009US20090093000 Glycoprotein and apolipoprotein biopolymer markers predictive of Alzheimers disease
04/01/2009EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
04/01/2009EP1824874B1 A processs for the purification of crude vancomycin
04/01/2009CN101397333A De-hydroxyl vancomycin, preparation method thereof, medicament composition and use thereof
03/2009
03/26/2009WO2009039185A1 Uses of immunologically modified scaffold for tissue prevascularization and cell transplantation
03/26/2009WO2009037592A2 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/26/2009CA2687689A1 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/18/2009CN100469788C 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives
03/12/2009US20090069534 Hydrochloride salts of a glycopeptide phosphonate derivative
03/12/2009US20090069220 Dna-binding polyamide drug conjugates
03/11/2009EP1805211B1 Purification of glycopeptides
03/05/2009US20090062182 Deuterium-enriched dalbavancin
03/04/2009EP2030982A1 Glycopeptide antibiotic derivative
02/2009
02/26/2009US20090053828 Detection of glycopeptides and glycoproteins for medical diagnostics
02/25/2009CN101374856A Inhibiting tumor cell invasion, metastasis and angiogenesis
02/25/2009CN100463917C Reductive alkylation of glycopeptide antibiotics
02/19/2009US20090048427 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
02/18/2009CN101370516A Soluble fragments of the SARS-CoV spike glycoprotein
02/17/2009US7491701 Peptides that bind to HSP90 proteins
02/05/2009WO2009017154A1 Method for producing peptide
02/05/2009CA2694542A1 Method for producing peptide
02/04/2009CN100457908C Recombinant stratum corneum chymotryptic enzyme (SCCE)
01/2009
01/29/2009WO2008070049A3 Peptide and treatment for hiv-1 infection
01/29/2009US20090030185 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
01/29/2009US20090029906 Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
01/28/2009CN100455596C Cell surface molecule mediating cell adhesion and signal transmission
01/27/2009CA2236837C Detection of mammary tumor virus-like sequences in human breast cancer
01/15/2009US20090017073 Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
01/14/2009CN101343313A Glucose dipeptide compounds, preparation method and application thereof
01/08/2009WO2009006620A1 Oligosialic acid derivatives, methods of manufacture, and immunological uses
01/08/2009US20090010944 Oligosialic acid derivatives, methods of manufacture, and immunological uses
01/08/2009CA2690440A1 Oligosialic acid derivatives, methods of manufacture, and immunological uses
01/07/2009CN101341167A Process for the purification of macrolide antibiotics
01/06/2009US7473680 Forming a convalent conjugate of a peptide, EPO, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety
01/06/2009US7473671 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
12/2008
12/31/2008WO2008110868A3 Proliferated islets
12/31/2008CA2690943A1 Conjugates containing hydrophilic spacer linkers
12/30/2008US7470776 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
12/23/2008US7468420 Process for purifying glycopeptide phosphonate derivatives
12/18/2008US20080312408 Method of Separating a Peptidoglycan Recognition Protein From a Hemolymph Tenebrio Molitor Larvae
12/18/2008US20080312407 Glycopeptide phosphonate derivatives
12/11/2008US20080305991 Factor IX: remodeling and glycoconjugation of factor IX
12/10/2008EP2000474A1 Method for production of peptide thioester compound
12/10/2008EP1355920B9 Extractive purification of lipopeptide antibiotics
12/10/2008EP1278549B1 Composition containing a cyclodextrin and a glycopeptide antibiotic
12/09/2008US7462687 Prodrugs of vancomycin with hydrolysis resistant polymer linkages
11/2008
11/27/2008CA2687493A1 Recombinant protein production in avian ebx r cells
11/26/2008EP1994046A1 Presentation of recognition motifs by a multivalent matrix grafted onto a solid support
11/20/2008WO2008140973A1 Semi-synthetic glycopeptides with antibacterial activity
11/12/2008CN101302248A Production method of high-purity teicoplanin
10/2008
10/30/2008US20080268504 Glycorandomization and Production of Novel Vancomycin Analogs
10/29/2008EP1984023A2 Soluble fragments of the sars-cov spike glycoprotein
10/23/2008US20080260691 Conjugated with amino acids, peptides, glycopeptides; bioavailability
10/21/2008US7439322 Nucleic acid; glycosylation
10/21/2008US7438890 Binding peptides for carcinoembryonic antigen (CEA)
10/09/2008US20080247950 Proteases of human kallikrein 2 (hK2); tissue imaging
10/02/2008WO2008076483A3 Rapid vancomycin derivative preparation via neoglycosylation
10/02/2008US20080242846 O-linked glycosylation of peptides
10/02/2008US20080242597 Antibiotic compounds
09/2008
09/25/2008US20080233599 Immunogenic glycopeptides, screening, preparation and uses
09/25/2008US20080233147 Circovirus sequences associated with piglet weight loss disease (PWD)
09/18/2008US20080227963 Process for preparing glycopeptide phosphonate derivatives
09/18/2008US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer
09/17/2008CN100418980C Process for purifying glycopeptide phospohonate derivatives
09/12/2008WO2008108505A1 Novel nuclear translocation peptide
09/12/2008WO2008042421A3 Peptides derived from the c2 domain of epsilon pkc, and use thereof
09/10/2008CN100417661C Hydrochloride salts of a glycopeptide phosphonate derivative
09/09/2008CA2546625C Glycopeptide antibiotic derivatives
09/09/2008CA2133644C Process for making vancomycin
09/04/2008WO2008028050A3 Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods
09/04/2008US20080214648 Hiv Prodrugs Cleavable by Cd26
09/04/2008US20080214444 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
09/04/2008US20080213828 Glycoprotein synthesis
08/2008
08/28/2008US20080207492 Crossing blood-brain barrier; central nervous system disorders; psychological disorders; behavioral disorders
08/28/2008US20080206270 vaccines that rely on eliciting cellular immune responses, specifically induction of cytotoxic T lymphocytes (CTL), against cancer cells and virus-infected cells via administration of a vaccine comprising a fusion peptide or a modified peptide; derived from antigens PRAME, OFA/iLRP, STEAP and SURVIVIN
08/28/2008US20080206141 Optical Imaging Contrast Agents
08/27/2008EP1960418A1 Process for the purification of macrolide antibiotics
08/26/2008US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety
08/21/2008WO2008100966A1 Gdnf-derived peptides
08/21/2008US20080200372 Glycosaminoglycan Peptides Derived From Connective Tissues And Use Thereof In The Prevention Of Arthritis And Other Degenerative Medical Conditions
08/20/2008EP1461445B1 Glycoprotein remodeling using endoglycanases
08/20/2008EP1087992B1 Antithrombotic compounds
08/14/2008US20080194465 Cross-linked glycopeptide-cephalosporin antibiotics
08/14/2008US20080194464 Chemical intermediate thereto; effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA)
08/13/2008EP1956085A2 Carbohydrate crosslinked glycoprotein crystals
08/07/2008WO2008076483A9 Rapid vancomycin derivative preparation via neoglycosylation
08/06/2008CN100408596C Process for pretreating vancomycin ferment fluid for HPLC analysis
07/2008
07/30/2008EP1355920B1 Extractive purification of lipopeptide antibiotics
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 34